June 8, 2023
Many Americans, including Minnesotans, skip doses or ration medications due to their high costs. To address this issue, states across the country have funded medication repository programs, which take in unused medications for redistribution.
Since late 2020, Minnesota’s medication repository program (MRP), administered by RoundtableRx, has supplied 30,270 days of medications to Minnesotans.
Each donated product undergoes a rigorous quality and safety inspection by a pharmacist before being accepted for inventory. Clinics and pharmacies then order inventory from the MRP to dispense to under-resourced Minnesotans at little to no-cost.
Since its inception, RoundtableRx has been operating under a pharmacy wholesale license, which enables them to redistribute medications through partnerships with clinics and pharmacies. These partner sites assume the role of dispensing repository medications to patients in need.
RoundtableRX’s medications are reserved for Minnesota residents who are uninsured or ‘underinsured.’ Because their inventory fluctuates, RoundtableRx is intended as a safety net program for affordable medications during challenging times (coverage lapse, Medicare ‘donut hole’, etc.), or for patients that do not qualify for insurance.
Prescribers and pharmacists interested in accessing these medications for their patients can learn how to on the RoundtableRX website.
June 11, 2026
The MMA has joined a federal multidistrict litigation (MDL) against MultiPlan (recently rebranded to Claritev) and major insurers, including UnitedHealth, Elevance, Humana, Aetna, and Cigna, alleging that they conspired to systematically underpay healthcare practitioners for reimbursements for out-of-network services, which often fail to cover operating costs.
June 11, 2026
On June 9, the University of Minnesota, University of Minnesota Physicians (UMP) and Fairview Health Services finalized an agreement on funding for the university's healthcare programs, including the medical school.
June 11, 2026
A federal judge on June 8 nixed the Trump administration's $100,000 price tag on new H-1B visas, saying the fee is a tax and that only Congress can create new taxes.